Oyunbileg Bavuu - Publications

Emerging roles of the cGAS/STING pathway in cardiovascular diseases.

Journal: The Journal of clinical investigation

Published: July 01, 2026

LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Attenuates Vascular Inflammation and Atherosclerosis in Apolipoprotein E-deficient Mice.

Journal: The journal of medical investigation : JMI

Published: April 23, 2026

Ligand-Specific Notch Signaling in Atherosclerosis: Implications for Inflammation and Plaque Stability.

Journal: Journal of atherosclerosis and thrombosis

Published: April 16, 2026

Esaxerenone Attenuates Atherogenesis and Vascular Dysfunction in Apolipoprotein E-Deficient Mice.

Journal: International heart journal

Published: September 10, 2025

Toll-like receptor 9 promotes aortic chondrogenesis and calcification in apolipoprotein E-deficient mice.

Journal: Heart and vessels

Published: July 14, 2025

A novel mineralocorticoid receptor blocker, CS-3150, improves insulin resistance and reduces inflammation in db/db mice.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Published: February 01, 2025

LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice.

Journal: Journal of atherosclerosis and thrombosis

Published: April 14, 2024

Innate Immune System Regulated by Stimulator of Interferon Genes, a Cytosolic DNA Sensor, Regulates Endothelial Function.

Journal: Journal of the American Heart Association

Published: November 10, 2023

Esaxerenone, a selective mineralocorticoid receptor blocker, improves insulin sensitivity in mice consuming high-fat diet.

Journal: European journal of pharmacology

Published: May 24, 2022